Imiquimod 5% cream treats vulvar intraepithelial neoplasia effectively
This article has no abstract so we have provided the first paragraph of the full text.
Surgical treatment of vulvar intraepithelial neoplasia (VIN) can cause disfigurement of the vulva and does not always prevent recurrence or progression because the most common cause of these lesions, human papillomavirus (HPV), is not eliminated. A less-invasive and more-effective treatment is, therefore, required. To address this need, van Seters et al. investigated the efficacy of a topical formulation of imiquimod, an immune-response modifier that is known to promote apoptosis in tumor cells.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.